Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers

Scientific Reports
Christian SchoergenhoferBernd Jilma

Abstract

Defibrotide is approved for the treatment of sinusoidal obstruction syndrome after allogeneic stem cell transplantation. The exact mode of action of defibrotide is unclear and human in vivo data are scarce. In this randomized, double blind, crossover trial we included 20 healthy volunteers. Four were randomized to receive placebo, while 16 received a 2 ng/kg bodyweight bolus of lipopolysaccharide (LPS). Infusion of 6.25 mg/kg defibrotide or placebo was started one hour before the injection of the LPS bolus. Plasma levels of prothrombin fragments F1 + 2, thrombin-antithrombin complexes, von Willebrand factor, E-selectin, tissue-type plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1), plasmin-antiplasmin complexes (PAP), tumor necrosis factor-α, interleukin 6, and C-reactive protein were measured. Thromboelastometry was performed. Infusion of defibrotide did not reduce the LPS-induced activation of coagulation, the endothelium or the release of pro-inflammatory cytokines. However, defibrotide increased t-PA antigen levels by 31% (Quartiles: 2-49%, p = 0.026) and PAP concentrations by 13% (-4-41%, p = 0.039), while PAI-1 levels remained unaffected. Moreover, defibrotide reduced C-reactive protein levels by 13%...Continue Reading

References

Jun 15, 1992·Thrombosis Research·H P Klöcking
Jan 1, 1989·The Journal of International Medical Research·E M PoglianiC Marelli
Dec 22, 1999·Circulation·T PernerstorferB Jilma
Mar 7, 2001·Archives of Pathology & Laboratory Medicine·K RuzickaI Schwarzinger
Jul 10, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·G CellaJ Fareed
Oct 29, 2002·The Journal of Infectious Diseases·Ursula M HollensteinBernd Jilma
Jun 12, 2004·Critical Care Medicine·Ulla DerhaschnigBernd Jilma
Jan 29, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M TobuJ Fareed
Dec 6, 2006·Translational Research : the Journal of Laboratory and Clinical Medicine·Florian B Mayr, Bernd Jilma
Feb 4, 2009·Journal of Thrombosis and Haemostasis : JTH·F B MayrB Jilma
Oct 8, 2009·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Cinara L EchartMassimo Iacobelli
Feb 20, 2010·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul G RichardsonEva C Guinan
Mar 17, 2010·Srpski arhiv za celokupno lekarstvo·Dragana JevtićIvo Elezović
Jul 8, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·C L EchartM Iacobelli
Nov 26, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Ivo M B FrancischettiMichael Waisberg
May 18, 2013·Vascular Pharmacology·R PescadorM E Ferrero
Sep 23, 2014·Clinical Pharmacology and Therapeutics·A F Suffredini, R J Noveck
Aug 31, 2016·Drug Design, Development and Therapy·Paola TocchettiMark Eller
Nov 22, 2016·Clinical Pharmacology in Drug Development·Kazuo UmemuraAtsushi Kikuta
Aug 11, 2017·Thrombosis and Haemostasis·Christian SchoergenhoferBernd Jilma

❮ Previous
Next ❯

Citations

Apr 20, 2021·Journal of Thrombosis and Haemostasis : JTH·Sara FernándezPedro Castro

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Clinical Trials Mentioned

NCT02876601

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.